Healthy Returns: What drugmakers are saying about Trump’s looming pharmaceutical tariffs
What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its glucose monitoring system.
You are not logged in so some information on this page has been withheld. To see more, please log in.